BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16626582)

  • 61. Novel alpha-galactosidase A mutation in a female with recurrent strokes.
    Tuttolomondo A; Duro G; Miceli S; Di Raimondo D; Pecoraro R; Serio A; Albeggiani G; Nuzzo D; Iemolo F; Pizzo F; Sciarrino S; Licata G; Pinto A
    Clin Biochem; 2012 Nov; 45(16-17):1525-30. PubMed ID: 22820434
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prevalence of Fabry disease in young patients with cryptogenic ischemic stroke.
    Dubuc V; Moore DF; Gioia LC; Saposnik G; Selchen D; Lanthier S
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1288-92. PubMed ID: 23168217
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevalence and Clinical Characteristics of Fabry Disease in Chinese Patients With Hypertrophic Cardiomyopathy.
    Xiao Y; Sun Y; Tian T; Wang TJ; Zhao RX; Zhang Y; Wang LP; Liu YX; Lu CX; Zhou XL; Yang WX
    Am J Med Sci; 2021 Sep; 362(3):260-267. PubMed ID: 34266644
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body.
    Oikawa M; Sakamoto N; Kobayashi A; Suzuki S; Yoshihisa A; Yamaki T; Nakazato K; Suzuki H; Saitoh S; Kiko Y; Nakano H; Hayashi T; Kimura A; Takeishi Y
    BMC Cardiovasc Disord; 2016 May; 16():83. PubMed ID: 27160240
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Late-onset and classic phenotypes of Fabry disease in males with the
    Valtola K; Hedman M; Kantola I; Walls S; Helisalmi S; Maria M; Raivo J; Auray-Blais C; Kuusisto J
    Open Heart; 2023 Mar; 10(1):. PubMed ID: 36927868
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Targeted Screening of Fabry Disease in Male Hemodialysis Patients in Brazil Highlights Importance of Family Screening.
    Silva CA; Barreto FC; Dos Reis MA; Moura Junior JA; Cruz CM
    Nephron; 2016; 134(4):221-230. PubMed ID: 27576502
    [TBL] [Abstract][Full Text] [Related]  

  • 67. New mutations in the GLA gene in Brazilian families with Fabry disease.
    Turaça LT; Pessoa JG; Motta FL; Muñoz Rojas MV; Müller KB; Lourenço CM; Junior Marques W; D'Almeida V; Martins AM; Pesquero JB
    J Hum Genet; 2012 Jun; 57(6):347-51. PubMed ID: 22551898
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification of a Novel GLA Gene Mutation, p.Ile239Met, in Fabry Disease With a Predominant Cardiac Phenotype.
    Csányi B; Hategan L; Nagy V; Obál I; Varga ET; Borbás J; Tringer A; Eichler S; Forster T; Rolfs A; Sepp R
    Int Heart J; 2017 May; 58(3):454-458. PubMed ID: 28496025
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fabry disease presenting as apical left ventricular hypertrophy in a patient carrying the missense mutation R118C.
    Caetano F; Botelho A; Mota P; Silva J; Leitão Marques A
    Rev Port Cardiol; 2014 Mar; 33(3):183.e1-5. PubMed ID: 24661928
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Frequency of Fabry disease in patients with small-fibre neuropathy of unknown aetiology: a pilot study.
    Tanislav C; Kaps M; Rolfs A; Böttcher T; Lackner K; Paschke E; Mascher H; Laue M; Blaes F
    Eur J Neurol; 2011 Apr; 18(4):631-6. PubMed ID: 20860754
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A novel mutation of α-galactosidase A gene causes Fabry disease mimicking primary erythromelalgia in a Chinese family.
    Ge W; Wei B; Zhu H; Miao Z; Zhang W; Leng C; Li J; Zhang D; Sun M; Xu X
    Int J Neurosci; 2017 May; 127(5):448-453. PubMed ID: 27211852
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A nonsense mutation (R220X) in the alpha-galactosidase A gene causes typical Fabry disease in both genders.
    Maki N; Komatsuda A; Wakui H; Oyama Y; Kodama T; Ohtani H; Kigawa A; Aiba N; Imai H; Motegi M; Yamaguchi A; Sawada K
    Clin Nephrol; 2004 Mar; 61(3):185-90. PubMed ID: 15077869
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Novel GLA gene mutations in two Chinese families with classic Fabry disease.
    Wang ZX; Zhang Y; Bu DF; Zhang W; Yuan Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):489-92. PubMed ID: 16215932
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Two novel mutations in the alpha-galactosidase A gene in Chinese patients with Fabry disease.
    Yang CC; Lai LW; Whitehair O; Hwu WL; Chiang SC; Lien YH
    Clin Genet; 2003 Mar; 63(3):205-9. PubMed ID: 12694230
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fabry disease: a new approach for the screening of females in high-risk groups.
    Pasqualim G; Simon L; Sperb-Ludwig F; Burin MG; Michelin-Tirelli K; Giugliani R; Matte U
    Clin Biochem; 2014 May; 47(7-8):657-62. PubMed ID: 24582695
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Diagnostic dilemmas in Fabry disease: a case series study on GLA mutations of unknown clinical significance.
    Smid BE; Hollak CE; Poorthuis BJ; van den Bergh Weerman MA; Florquin S; Kok WE; Lekanne Deprez RH; Timmermans J; Linthorst GE
    Clin Genet; 2015 Aug; 88(2):161-6. PubMed ID: 25040344
    [TBL] [Abstract][Full Text] [Related]  

  • 77. α-Galactosidase A Genotype N215S Induces a Specific Cardiac Variant of Fabry Disease.
    Oder D; Liu D; Hu K; Üçeyler N; Salinger T; Müntze J; Lorenz K; Kandolf R; Gröne HJ; Sommer C; Ertl G; Wanner C; Nordbeck P
    Circ Cardiovasc Genet; 2017 Oct; 10(5):. PubMed ID: 29018006
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification of point mutations in the alpha-galactosidase A gene in classical and atypical hemizygotes with Fabry disease.
    Sakuraba H; Oshima A; Fukuhara Y; Shimmoto M; Nagao Y; Bishop DF; Desnick RJ; Suzuki Y
    Am J Hum Genet; 1990 Nov; 47(5):784-9. PubMed ID: 2171331
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nationwide screening of Fabry disease in patients with hypertrophic cardiomyopathy in Czech Republic.
    Zemánek D; Januška J; Honěk T; Čurila K; Kubánek M; Šindelářová Š; Zahálková L; Klofáč P; Laštůvková E; Lichnerová E; Aiglová R; Lhotský J; Vondrák J; Dostálová G; Táborský M; Kasper D; Linhart A
    ESC Heart Fail; 2022 Dec; 9(6):4160-4166. PubMed ID: 36087038
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Founder effect of Fabry disease due to p.F113L mutation: Clinical profile of a late-onset phenotype.
    Azevedo O; Gal A; Faria R; Gaspar P; Miltenberger-Miltenyi G; Gago MF; Dias F; Martins A; Rodrigues J; Reimão P; Pereira O; Simões S; Lopes E; Guimarães MJ; Sousa N; Cunha D
    Mol Genet Metab; 2020 Feb; 129(2):150-160. PubMed ID: 31519519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.